A community hospital-based congestive heart failure program: Impact on length of stay, admission and readmission rates, and cost

American Journal of Managed Care

Volumn 5, Issue 1, 1999, Pages 37-43

  Rauh, R Andrew ^a   Schwabauer, Nancy J ^b   Enger, Elaine L ^b   Moran, John F ^b  

^a Midwest Heart Research Foundation   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; INOTROPIC AGENT; NITRATE;

ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST CONTROL; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

CARDIOLOGY SERVICE, HOSPITAL; CRITICAL PATHWAYS; HEART FAILURE, CONGESTIVE; HOSPITAL COSTS; HOSPITALS, COMMUNITY; HUMANS; ILLINOIS; LENGTH OF STAY; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PATIENT CARE TEAM; PATIENT EDUCATION; RETROSPECTIVE STUDIES;

EID: 0032890718     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 21:951-957.
2. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995;92:2764-2784.
3. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971;285:1441-1446.
4. Furberg CD, Yusuf S, Thom TJ. Potential for altering the natural history of congestive heart failure: Need for large clinical trials. Am J Cardiol 1985;55:45A-47A.
5. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985;33:595-601.
6. Rich MW, Freedland KE. Effect of DRGs on 3-month readmission rate of geriatric patients with congestive heart failure. Am J Public Health 1988;78:680-682.
7. MedPAR [database]. Baltimore, MD: Health Care Financing Administration; 1994.
8. Levit KR, Lazenby HC, Corvan CA, et al. National health expenditures, 1990. Health Care Financ Rev 1991;13:29-54.
9. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: Traits among urban blacks. Arch Intern Med 1988;148:2013-2016.
10. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting: Comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979;139:635-638.
11. Hulka BS, Cassel JC, Kupper LL, Burdette JA. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health 1976;66:847-853.
12. Heaney L, Marius-Nunez AL, Silber E, Antonio C, Denes P. Intermittent inotropic infusions: Critical care in an outpatient setting. CHF July/August 1995:15-18.
13. Living with heart disease: Is it heart failure? In: Clinical Practice Guideline: Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Rockville, MD: US Dept of Health and Human Services; June 1994. AHCPR publication 94-0614.
14. Rich MW, Beckman V, Wittenberg C, Leven CL, Freedland KE, Garney RM. A multidisciplinary intervention to prevent readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333:1190-1195.
15. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive management program on the hospitalization rate for patients with advanced heart failure. [Abstract] J Am Coll Cardiol February 1995:264A.
16. Friedman AW, Minella RA, Silver SJ, Lipman RC, McEwen S. Reduced hospital admissions with chronic inotropic therapy for resistant congestive heart failure. CHF November/December 1995:19-23.
17. Shipley JB, Tolman D, Hastillo A, Hess ML. Milrinone: Basic and clinical pharmacology and acute and chronic management. Am J Med Sci 1996;311:1-6.
18. Jennison SH, Dhar SC, Derfler MC, Miller LW. Outpatient use of continuous intravenous milrinone for advanced heart failure. CHF September/October 1996:4-9.
19. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986;74 (suppl II):II-38.
20. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-1295.